• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA FTX通过调节枯否细胞的M1/M2极化来抑制非酒精性脂肪性肝病向肝细胞癌的进展。

LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells.

作者信息

Wu Huajun, Zhong Zhiwei, Wang Anji, Yuan Chunhui, Ning Ke, Hu Huanhuan, Wang Chao, Yin Xiangbao

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi Province China.

Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province China.

出版信息

Cancer Cell Int. 2020 Jun 24;20:266. doi: 10.1186/s12935-020-01354-0. eCollection 2020.

DOI:10.1186/s12935-020-01354-0
PMID:32595415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7315496/
Abstract

BACKGROUND

The effect of lncRNA FTX on non-alcoholic fatty liver disease (NAFLD) conversion to hepatocellular carcinoma (HCC) is unclear.

METHODS

In our study, C57BL/6 mice was fed with high fat diet for obtaining NAFLD mouse model, and diethylnitrosamine induced the formation of HCC tumor. The expression of iNOS and CD206 in tissues were examined using immunohistochemistry. In addition, qRT-PCR was implemented to detect the expression of FTX and mRNAs. The percentage of M1 and M2 Kupffer cells (KCs) were determined using flow cytometry. The pathological change in liver tissues was displayed by H&E staining. Besides, immunofluorescence assay was performed to ensure the primary KCs through labeling F4/80.

RESULTS

Here, we found that the expression of FTX and the ratio of M1/M2 KCs in liver tissues from NAFLD-transformed HCC (NAFLD-HCC) patients lower than in liver tissues from NAFLD patients. Subsequently, we revealed that the expression of FTX and M1/M2 KCs ratio were downregulated during NAFLD conversion to HCC. Importantly, increasing of FTX inhibited HCC tumor growth, improved liver damage and promoted M1 polarization of KCs during NAFLD conversion to HCC, while these effects of FTX were reversed by inactivating of KCs. Finally, in vitro experiments, our data indicated that FTX facilitated the M1 polarization of KCs.

CONCLUSION

In conclusion, our results demonstrated that upregulation of FTX suppressed NAFLD conversion to HCC though promoting M1 polarization of KCs. Our findings presented a new regulatory mechanism for NAFLD conversion to HCC, and provided a new biomarker for inhibiting this conversion.

摘要

背景

长链非编码RNA FTX对非酒精性脂肪性肝病(NAFLD)转化为肝细胞癌(HCC)的影响尚不清楚。

方法

在我们的研究中,给C57BL/6小鼠喂食高脂肪饮食以获得NAFLD小鼠模型,并用二乙基亚硝胺诱导HCC肿瘤形成。使用免疫组织化学检测组织中诱导型一氧化氮合酶(iNOS)和CD206的表达。此外,实施qRT-PCR检测FTX和mRNA的表达。使用流式细胞术测定M1和M2库普弗细胞(KCs)的百分比。通过苏木精-伊红(H&E)染色显示肝组织的病理变化。此外,进行免疫荧光测定以通过标记F4/80来确定原代KCs。

结果

在这里,我们发现NAFLD转化的HCC(NAFLD-HCC)患者肝组织中FTX的表达以及M1/M2 KCs的比例低于NAFLD患者的肝组织。随后,我们发现FTX的表达和M1/M2 KCs比例在NAFLD转化为HCC的过程中下调。重要的是,在NAFLD转化为HCC的过程中,FTX的增加抑制了HCC肿瘤生长,改善了肝损伤并促进了KCs的M1极化,而FTX的这些作用被KCs的失活所逆转。最后,在体外实验中,我们的数据表明FTX促进了KCs的M1极化。

结论

总之,我们的结果表明,FTX的上调通过促进KCs的M1极化抑制了NAFLD向HCC的转化。我们的发现提出了一种NAFLD转化为HCC的新调节机制,并为抑制这种转化提供了一种新的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/84507c1ce14f/12935_2020_1354_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/94e239bb65df/12935_2020_1354_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/42f8c9850269/12935_2020_1354_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/04981d533076/12935_2020_1354_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/e93711f5bb7f/12935_2020_1354_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/b3d6d306b5a8/12935_2020_1354_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/84507c1ce14f/12935_2020_1354_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/94e239bb65df/12935_2020_1354_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/42f8c9850269/12935_2020_1354_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/04981d533076/12935_2020_1354_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/e93711f5bb7f/12935_2020_1354_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/b3d6d306b5a8/12935_2020_1354_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26ae/7315496/84507c1ce14f/12935_2020_1354_Fig6_HTML.jpg

相似文献

1
LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells.长链非编码RNA FTX通过调节枯否细胞的M1/M2极化来抑制非酒精性脂肪性肝病向肝细胞癌的进展。
Cancer Cell Int. 2020 Jun 24;20:266. doi: 10.1186/s12935-020-01354-0. eCollection 2020.
2
Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization.lncRNA SNHG20 的沉默通过调节肝枯否细胞极化延缓非酒精性脂肪性肝病向肝细胞癌的进展。
IUBMB Life. 2019 Dec;71(12):1952-1961. doi: 10.1002/iub.2137. Epub 2019 Aug 13.
3
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.M2 库普弗细胞促进 M1 库普弗细胞凋亡:一种针对酒精性和非酒精性脂肪性肝病的保护机制。
Hepatology. 2014 Jan;59(1):130-42. doi: 10.1002/hep.26607. Epub 2013 Nov 20.
4
Lapachol treats non-alcoholic fatty liver disease by modulating the M1 polarization of Kupffer cells via PKM2.拉帕醌通过 PKM2 调节枯否细胞的 M1 极化来治疗非酒精性脂肪性肝病。
Int Immunopharmacol. 2023 Jul;120:110380. doi: 10.1016/j.intimp.2023.110380. Epub 2023 May 26.
5
Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB.冬凌草甲素通过ROS-NF-κB调节库普弗细胞的极化状态以减轻非酒精性脂肪性肝病。
Int Immunopharmacol. 2021 Dec;101(Pt B):108290. doi: 10.1016/j.intimp.2021.108290. Epub 2021 Oct 28.
6
Major roles of kupffer cells and macrophages in NAFLD development.枯否细胞和巨噬细胞在非酒精性脂肪性肝病发展中的主要作用。
Front Endocrinol (Lausanne). 2023 May 19;14:1150118. doi: 10.3389/fendo.2023.1150118. eCollection 2023.
7
Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis.白细胞介素-22 通过 STAT3/Erk/Akt 信号通路调节枯否细胞极化以减轻肝纤维化。
Life Sci. 2021 Jan 1;264:118677. doi: 10.1016/j.lfs.2020.118677. Epub 2020 Oct 28.
8
LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.长链非编码RNA MEG3通过HuR/CCL5轴降低肝癌中M2/M1巨噬细胞的比例
J Hepatocell Carcinoma. 2024 Mar 11;11:543-562. doi: 10.2147/JHC.S449090. eCollection 2024.
9
MicroRNA-206 promotes the recruitment of CD8 T cells by driving M1 polarisation of Kupffer cells.microRNA-206 通过驱动枯否细胞 M1 极化促进 CD8 T 细胞的募集。
Gut. 2022 Aug;71(8):1642-1655. doi: 10.1136/gutjnl-2021-324170. Epub 2021 Oct 27.
10
[Interleukin-17-mediated inflammation promotes nonalcoholic fatty liver disease in mice with regulation of M1-type macrophage polarization].[白细胞介素-17介导的炎症通过调节M1型巨噬细胞极化促进小鼠非酒精性脂肪性肝病]
Zhonghua Gan Zang Bing Za Zhi. 2018 Dec 20;26(12):916-921. doi: 10.3760/cma.j.issn.1007-3418.2018.12.008.

引用本文的文献

1
Comprehensive review of macrophage models: primary cells and immortalized lines across species.巨噬细胞模型的全面综述:跨物种的原代细胞和永生化细胞系
Front Immunol. 2025 Aug 20;16:1640935. doi: 10.3389/fimmu.2025.1640935. eCollection 2025.
2
Investigating the Diagnostic Utility of LncRNA GAS5 in NAFLD Patients.研究长链非编码RNA GAS5在非酒精性脂肪性肝病患者中的诊断效用。
Biomedicines. 2025 Aug 1;13(8):1873. doi: 10.3390/biomedicines13081873.
3
The role of liver macrophages in viral liver pathogenesis.肝脏巨噬细胞在病毒性肝病发病机制中的作用。

本文引用的文献

1
Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management.非酒精性脂肪性肝病:流行病学、风险因素、诊断和治疗的综述。
Intern Med J. 2020 Sep;50(9):1038-1047. doi: 10.1111/imj.14709.
2
Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization.lncRNA SNHG20 的沉默通过调节肝枯否细胞极化延缓非酒精性脂肪性肝病向肝细胞癌的进展。
IUBMB Life. 2019 Dec;71(12):1952-1961. doi: 10.1002/iub.2137. Epub 2019 Aug 13.
3
ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.
J Leukoc Biol. 2025 Sep 1;117(9). doi: 10.1093/jleuko/qiaf088.
4
LncRNA FTX promotes colorectal cancer radioresistance through disturbing redox balance and inhibiting ferroptosis miR-625-5p/SCL7A11 axis.长链非编码RNA FTX通过扰乱氧化还原平衡和抑制铁死亡的miR-625-5p/SCL7A11轴促进结直肠癌放疗抵抗。
World J Gastroenterol. 2025 Apr 28;31(16):104305. doi: 10.3748/wjg.v31.i16.104305.
5
Glycolysis-related lncRNA FTX upregulates YAP1 to facilitate colorectal cancer progression via sponging miR-215-3p.糖酵解相关长链非编码RNA FTX通过海绵吸附miR-215-3p上调YAP1以促进结直肠癌进展。
Sci Rep. 2025 Mar 22;15(1):9929. doi: 10.1038/s41598-025-94638-2.
6
LncRNA FTX accelerates the progression of hepatocellular carcinoma by FTX/miR-374a-3p/HMGB1 pathway.长链非编码RNA FTX通过FTX/miR-374a-3p/HMGB1通路加速肝细胞癌进展。
Int J Med Sci. 2025 Feb 18;22(6):1363-1374. doi: 10.7150/ijms.106867. eCollection 2025.
7
Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis.长链非编码RNA在代谢功能障碍相关脂肪性肝病和肝纤维化发病机制中的作用机制
eGastroenterology. 2024 Nov;2(4):e100115. doi: 10.1136/egastro-2024-100115. Epub 2024 Nov 18.
8
Long Non-coding RNAs Regulating Macrophage Polarization in Liver Cancer.长链非编码 RNA 在肝癌中调控巨噬细胞极化。
Curr Pharm Des. 2024;30(27):2120-2128. doi: 10.2174/0113816128311861240523075218.
9
Communication molecules (ncRNAs) mediate tumor-associated macrophage polarization and tumor progression.通信分子(非编码RNA)介导肿瘤相关巨噬细胞极化和肿瘤进展。
Front Cell Dev Biol. 2024 Mar 8;12:1289538. doi: 10.3389/fcell.2024.1289538. eCollection 2024.
10
Epigenetic modifications in obesity-associated diseases.肥胖相关疾病中的表观遗传修饰。
MedComm (2020). 2024 Feb 24;5(2):e496. doi: 10.1002/mco2.496. eCollection 2024 Feb.
内质网驻留型 Nogo-B 通过 oxLDL 脂噬的代谢重编程加速非酒精性脂肪性肝病相关 HCC。
Nat Commun. 2019 Jul 29;10(1):3391. doi: 10.1038/s41467-019-11274-x.
4
Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.长链非编码 RNA EPB41L4A-AS2 通过海绵吸附 miR-301a-5p 和靶向 FOXL1 抑制肝细胞癌的发展。
J Exp Clin Cancer Res. 2019 Apr 10;38(1):153. doi: 10.1186/s13046-019-1128-9.
5
Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.长链非编码 RNA (lncRNA) 小核仁 RNA 宿主基因 16 (SNHG16) 预测肝细胞癌的不良预后和索拉非尼耐药性。
Med Sci Monit. 2019 Mar 20;25:2079-2086. doi: 10.12659/MSM.915541.
6
The long noncoding RNA contributes to progression of hepatocellular carcinoma through up-regulation of PARP1.长链非编码 RNA 通过上调 PARP1 促进肝细胞癌的进展。
Biosci Rep. 2018 Jun 21;38(3). doi: 10.1042/BSR20180703. Print 2018 Jun 29.
7
Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.从 1998 年到 2015 年的真实世界经验:肝细胞癌患者的疾病表现和生存的时间趋势。
Cancer. 2018 Jun 15;124(12):2588-2598. doi: 10.1002/cncr.31373. Epub 2018 Apr 6.
8
Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling.长链非编码 RNA NKILA 通过调控 NF-κB 信号通路增强黄芩素对肝癌的抗癌作用。
Chem Biol Interact. 2018 Apr 1;285:48-58. doi: 10.1016/j.cbi.2018.02.027. Epub 2018 Feb 23.
9
Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.二甲双胍诱导非酒精性脂肪性肝病小鼠肝脏中编码转录组和非编码RNA的变化
Cell Physiol Biochem. 2018;45(4):1487-1505. doi: 10.1159/000487575. Epub 2018 Feb 16.
10
Macrophage plasticity, polarization, and function in health and disease.巨噬细胞的可塑性、极化及其在健康与疾病中的功能。
J Cell Physiol. 2018 Sep;233(9):6425-6440. doi: 10.1002/jcp.26429. Epub 2018 Mar 1.